[ACCESSWIRE]
LONDON, UK / ACCESSWIRE / October 14, 2016 / Active Wall St. announces the list of stocks for today's research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Healthcare sector. Companies recently under review include Sernova, SQI Diagnostics, Vanc Pharma, and Avivagen. Get all of our free research reports by signing up at:
http://www.activewallst.com/register/
On Thursday, October 13, 2016, at the end of trading session, the TSX Venture Composite index ended the day at 777.50, 0.90% higher, on a total volume of 161,003,048 shares.
Additionally, the Healthcare index was slightly down by 0.56%, ending the session at 81.13.
Active Wall St. has initiated research reports on the following equities: Sernova Corporation (TSX-V: SVA), SQI Diagnostics Inc. (TSX-V: SQD), Vanc Pharmaceuticals Inc. (TSX-V: NPH), and Avivagen Inc. (TSX-V: VIV). Register with us now for your free membership and research reports at: http://www.activewallst.com/register/.
Sernova Corp.
London, Canada headquartered clinical stage regenerative medicine company, Sernova Corp.'s stock dropped 1.75%, to finish Thursday's session at $0.28 with a total volume of 240,900 shares traded. Over the last one month, Sernova's shares have fallen by 3.45%. Shares of the Company, which engages in the development of medical technologies for the treatment of chronic debilitating metabolic diseases, are trading below its 50-day and 200-day moving averages of $0.30. See our research report on SVA.V at: http://www.activewallst.com/registration-3/?symbol=SVA.
SQI Diagnostics Inc.
Toronto, Canada headquartered life sciences company, SQI Diagnostics Inc.'s stock plummeted 10.00%, to close the day at $0.18. The stock recorded a trading volume of 10,173 shares. Shares of SQI Diagnostics, which develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada, are trading below their 50-day and 200-day moving averages. Moreover, the stock's 200-day moving average of $0.29 is greater than its 50-day moving average of $0.23. The complimentary research report on SQD.V at: http://www.activewallst.com/registration-3/?symbol=SQD.
Vanc Pharmaceuticals Inc.
On Thursday, shares in Richmond, Canada headquartered Vanc Pharmaceuticals Inc. ended the session 13.64% lower at $0.19 with a total volume of 247,470 shares traded. Shares of Vanc Pharma, which focuses on the manufacture and distribution of generic and over-the-counter pharmaceuticals, have advanced 5.56% in the past one month. The stock is trading above its 50-day moving average. The company's 200-day moving average of $0.30 is greater than its 50-day moving average of $0.18. Register for free and access the latest research report on NPH.V at: http://www.activewallst.com/registration-3/?symbol=NPH.
Avivagen Inc.
On Thursday, shares in Ottawa, Canada headquartered Avivagen Inc. recorded a trading volume of 1.73 million shares, which was higher than their three months average volume of 729,509 shares. The stock ended the day 5.41% lower at $0.17. Avivagen's stock has surged 20.00% in the last one month and 100.00% in the previous three months. Furthermore, the stock has rallied 200.00% in the past one year. Shares of the company, which development stage biotechnology company, designs, develops, manufactures, markets, and supports natural health products for livestock and companion animals in Canada, the US, Europe, and globally, are trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $0.16 is above its 200-day moving average of $0.10. Get free access to your research report on VIV.V at: http://www.activewallst.com/registration-3/?symbol=VIV.
Active Wall Street:
Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
AWS has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active Wall Street
